Top AI Companies in Minneapolis, MN (28)

Resilient & Sustainable Growth: Revenue increased in FY2024 and again in FY2025 to a record ~US$56.9B, with all three lines of service expanding. Growth in the Americas and EMEA helped offset softness in parts of Asia Pacific, indicating steady, if modest, momentum.

Innovation-Driven Growth: A multi‑year push includes roughly US$1.5B to expand and scale AI capabilities, alongside AI‑enabled platforms and dedicated AI hubs/factories. These investments are positioned to extend growth beyond core assurance and tax and to support new, tech‑enabled offerings.

Strong Market Position & Advantage: As one of the Big Four with record scale and repeated “Leader” placements in independent analyst evaluations, the firm operates from a top‑tier competitive position. Rising brand value and leadership recognition in selected consulting categories reinforce commercial strength.

Strong Revenue Growth: Consolidated revenues increased from $253 billion in 2024 to $270.6 billion in 2025, with quarterly gains such as Q4 2025 up 8% year over year. Growth was led primarily by Optum Rx and supported by steady contributions from Optum Insight.

Market Expansion: Expansion through acquisitions such as Holston Medical Group (August 2025) and Alegeus (July 2026), alongside earlier combinations like Change Healthcare and Atrius Health, broadened capabilities across care, pharmacy, and payments. These moves extend Optum’s platform into adjacent services and operating domains.

Diversified Revenue Streams: A multi-segment model—Rx, Insight, and Health—helps sustain aggregate growth even as individual lines vary, with pharmacy and technology businesses offsetting care-delivery softness. Parent-company commentary continuing to frame Optum as a growth engine and raising 2026 guidance underscores the benefit of this portfolio effect.

Product Line Growth: New offerings like Pulse (2026) and an AI Dubbing solution (2026), plus AI‑enabled language solutions and a global linguist marketplace (2025), extend the platform beyond core captioning. Company materials also emphasize a broader suite spanning live and prerecorded captioning, transcription, audio description, subtitling, and localization/dubbing.

Market Expansion: The February 2022 acquisition of Captionmax and National Captioning Canada added significant live‑captioning capabilities and a Canadian presence, later rebranded as 3Play Media Canada. A 2025 reintroduction emphasized multilingual video localization across 50+ languages, signaling entry into a wider global market.

Investor Backing & Capital Strength: A 2019 majority investment by Riverside Partners provides institutional support for a buy‑and‑build strategy and continued product and market expansion. Subsequent M&A and integration milestones reinforce available capital and sponsor‑driven scale‑up capacity.

Investor Backing & Capital Strength: Feedback suggests a recently secured $3 million seed round provides fresh capital to scale senior engineering capabilities and extend the 90-Day Production Guarantee.

Strategic Partnerships: Feedback suggests selection as an early Vercel AI implementation partner strengthens go-to-market reach and credibility for enterprise AI deployments.

Innovation-Driven Growth: Feedback suggests a distinct AI-native, anti-consultancy model with rapid production delivery and internal tooling (Shippy) underpins execution speed and measurable client outcomes.

Strong Revenue Growth: Comparable revenue increased in FY2025 and the company reports a positive start to FY2026 on a comparable basis while reaffirming its full-year comparable growth guidance.

Profitability: Adjusted EBIT margin rose in FY2025, and free cash flow improved alongside a higher proposed dividend, indicating strengthened operating performance and shareholder returns.

Strong Market Position & Advantage: The company is positioned as a leader in medical technology, with noted dominance in diagnostic imaging and continued momentum in Imaging and Precision Therapy helping sustain growth despite pressures elsewhere.

Strong Market Position & Advantage: Traction is demonstrated through named enterprise wins and public customer stories including Target and announcements naming Urban Outfitters, Mango, and Komar Brands. Positioning is strongest when the category is defined as supplier quality/compliance/traceability for retail and apparel, where it is described as a go-to specialist.

Investor Backing & Capital Strength: Capital strength is supported by a $50M Series B led by Insight Partners, cited as underpinning continued product expansion. Investor commentary in the funding context characterizes the company as a market leader in an industry needing modernization.

Innovation-Driven Growth: Product investment is evidenced by the January 2026 launch of Supply Chain Network Intelligence and messaging around an AI “co-pilot” and network intelligence layer. Recognition such as the AI Breakthrough 2024 award reinforces visibility around the AI-driven roadmap.

Strong Market Position & Advantage: Independent tracking repeatedly places Best Buy at or near the top of U.S. consumer‑electronics spend, and major newswires describe it as the nation’s largest consumer‑electronics chain. Scale, omnichannel reach and national recognition reinforce competitive standing.

Diversified Revenue Streams: Geek Squad, delivery/installation and protection plans are integrated into paid memberships, with additional contributions from Best Buy Ads and a curated online marketplace. These service and media layers add stickiness and profit levers beyond core product sales.

Strategic Partnerships: Shop‑in‑shop programs and brand tie‑ups, including IKEA kitchen and laundry studios, broaden traffic and attach opportunities. Premium vendor collaborations and in‑store experiences support higher‑value purchases and cross‑sell.

Strong Market Position & Advantage: Multiple industry and company sources characterize Entegris as a top-tier, often No. 1 or No. 2, supplier across microcontamination control, CMP consumables after the CMC Materials acquisition, and wafer carriers. Acquisitions and long-running product lines, plus independent trackers for FOUPs/FOSBs and CMP, underscore durable leadership in critical purity and handling niches.

Healthy Cash Flow: Recent quarters highlighted strong cash generation, including record free cash flow in Q3 2025 and debt paydown. Sequential stabilization with flat-to-slightly-up revenue accompanied by solid operating cash flow supports resilience through the cycle.

Future-Ready Strategy: The company is expanding advanced-node capacity with a major Taiwan site and a CHIPS Act-supported Colorado Springs center to scale filtration, FOUPs, and deposition materials output. Management emphasizes increasing content per wafer in filtration, deposition, and CMP as structural drivers to outgrow wafer-fab cycles over time.

Strong Market Position & Advantage: Within care enablement and digital front door, the company is described as a category leader with unusually comprehensive coverage across triage, navigation, scheduling, virtual visits, and a 50‑state clinical network. Third‑party lists (CB Insights, DHNY, AVIA) and scale signals (relationships with 75+ health systems and 30,000 employers) suggest rising standing among peers.

Strong Revenue Growth: Company materials cite triple‑digit annual sales growth alongside ongoing product launches and new deployments through 2025–2026. Reported reach of roughly 100M covered lives and expanding enterprise relationships indicate accelerating topline momentum.

Investor Backing & Capital Strength: A $60M Series A in 2024 aligns with an aggressive build‑and‑buy strategy that includes multiple acquisitions over a short period. This funding posture supports continued platform development and distribution expansion.